News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Mary Ann Liebert, Inc. Release: The Fourth Annual Conference On Regenerative Medicine

10/19/2005 5:10:17 PM

Rebuilding the Body, Restoring Function

LARCHMONT, N.Y.--(BUSINESS WIRE)--Nov. 5, 2003--At the Renaissance Washington, D. C. Hotel on November 17-19, leading researchers, scientists, physicians, and entrepreneurs in cellular therapies, Alzheimer's disease, tissue engineering, new ventures, and substitutive medicine: organ replacement and repair will share the latest advances in the provocative new field of Regenerative Medicine. Regenerative Medicine, a unique new approach to healing that uses the body's own genes, proteins, antibodies, and cells to repair organs and tissues. Members of the press will assemble on Tuesday November 18th, at 10:30 a.m. for a press conference with Dr. William Haseltine.

What: The Fourth Annual Conference on Regenerative Medicine: Rebuilding the Body, Restoring Function

When: November 17-19, 2003 Opening Monday, November 17, at 5:00 p.m. Concluding Wednesday, November 19, at 5:00 p.m.

Where: Renaissance Washington, D.C. Hotel, 999 Ninth Street N.W., Washington, D.C.

Who: William A. Haseltine, Ph.D., Chairman & CEO, Human Genome Sciences, Inc., conference chair, will present opening remarks and an overview November 17, at 5:00 p.m. on Regenerative Medicine: Rebuilding the Body, Restoring Function.

Robert S. Langer, Ph.D., Kenneth J. Germeshausen, Professor of Chemical and Biomedical Engineering, MIT will present a keynote address November 17, at 6:00 p.m. on Novel Biomaterials.

Donald W. Fink, Jr., Ph.D., Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, will speak Wednesday, November 19, from noon to 1:00 p.m. at the luncheon.

Linda Powers, Managing Director, Toucan Capital, will present a New Ventures Address November 19, at 1:00 p.m.

Sponsors: USF College of Medicine, Regenerative Medicine and Stem Cell Biology and Genetic Engineering News

Supporters: Human Genome Sciences, Inc., Toucan Capital Corp.

Details: For complete program and registration visit:

Press Conference: Tuesday, November 18, 10:30 a.m., Room 15


Mary Ann Liebert, Inc., Larchmont BioConferences International, Inc. Harriet I. Matysko, 914-834-3100 ext. 608

Source: Mary Ann Liebert, Inc.

Read at

comments powered by Disqus